Meadowhawk Biolabs
Marlborough, US · Founded 2021 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
PG
Peter GlickExecutive
JJ
James JerseyExecutive
JS
Jessica SullivanExecutive
GP
Glick PeterNamed on SEC filing
Board
HH
Herbert HooperBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$20.3M disclosed across 3 rounds · 2021–2024
▶$5MraisedJul 2024 · 8 investors · BiotechnologyRule 506(b)
▶$5MraisedJul 2024 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Peter GlickExecutive Officer, Director
- James JerseyExecutive Officer, Director
- Jessica SullivanExecutive Officer
- Herbert HooperDirector
- Offering amount
- $5M
- Amount sold
- $5M
- First sale
- Jul 2024
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$9.3MraisedMar 2023 · 8 investors · BiotechnologyRule 506(b)
▶$9.3MraisedMar 2023 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Glick PeterExecutive Officer, Director
- Jessica SullivanExecutive Officer
- Herbert HooperDirector
- James JerseyExecutive Officer, Director
- Offering amount
- $9.3M
- Amount sold
- $9.3M
- Minimum investment
- $250K
- First sale
- Aug 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
▶$6MraisedMar 2023 · 9 investors · BiotechnologyRule 506(b)
▶$6MraisedMar 2023 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Herbert HooperDirector
- Peter GlickExecutive Officer, Director
- James JerseyExecutive Officer, Director
- Jessica SullivanExecutive Officer
- Offering amount
- $6M
- Amount sold
- $6M
- Minimum investment
- $18.6K
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlapLabcorp7 shared keywordsLabcorp provides clinical laboratory testing, diagnostics, and lab data services for patients, healthcare providers, and biopharma companies, including genetic health panels, oncology testing, and self-ordered lab tests. It also offers AI-powered tools such as a results-explaining consumer app, a diagnostic assistant integrated into EHRs, and a laboratory data analytics platform to support drug development and clinical research.
IQVIA7 shared keywordsIQVIA provides data, analytics, AI, and technology-driven services for life sciences and healthcare organizations, spanning clinical development, real world evidence generation, and commercial execution. It offers integrated solutions for clinical trials, regulatory and safety compliance, and market analytics, including agentic AI products for commercial and R&D teams.
Contract7 shared keywordsContract Pharma is a trade media publication covering the pharmaceutical and biopharmaceutical industry, with a focus on contract development and manufacturing (CDMO) topics. It provides industry news, magazine issues, expert interviews, webinars, whitepapers, company directories, and event coverage for professionals in the pharma and biopharma sector.
Companies competing with Meadowhawk Biolabs for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- Who are Meadowhawk Biolabs's investors?
- Meadowhawk Biolabs's investors include Ampersand.
- How much funding has Meadowhawk Biolabs raised?
- Meadowhawk Biolabs has disclosed $20.3M raised across 3 rounds.
- Where is Meadowhawk Biolabs headquartered?
- Meadowhawk Biolabs is headquartered in Marlborough, US.